In this explainer, our analyst Nishka Kapoor writes on the recently released draft of the New Drugs, Medical Devices and Cosmetics Bill, 2022, while analysing the objectives that the Bill seeks to achieve and whether the draft legislation is equipped with the requisite provisions in order to regulate the highly competitive and significantly influential pharmaceutical and cosmetics industries in India.
The post New Drugs, Medical Devices and Cosmetics Bill, 2022: Progressive or Regressive? appeared first on Law and Other Things.